Nonalcoholic fatty liver disease and colorectal cancer: a two-sample bidirectional Mendelian randomization analysis

Li Yang
DOI: https://doi.org/10.1097/meg.0000000000002859
2024-10-31
European Journal of Gastroenterology & Hepatology
Abstract:Colorectal cancer (CRC) is one of four globally recognized cancers and second to lung cancer in terms of mortality [ 1 ]. The morbidity and mortality of CRC have been steadily rising in recent years. The development of screening technology, especially early screening, can promote the diagnosis of CRC and improve the 5-year survival rate by aiding in prevention and treatment [ 2 , 3 ]. Previous diseases may increase the risk of CRC, such as a history of severe psychiatric illness [ 4 ], type 2 diabetes mellitus [ 5 ], inflammatory bowel disease [ 6 ], and Crohn's disease [ 7 ]. Exploring more risk factors for the occurrence and development of CRC may be a necessary and effective way for early screening.
gastroenterology & hepatology
What problem does this paper attempt to address?